Dear Sirs,
Polyglucosan body myopathies are a clinically and genetically heterogeneous group of muscle disorders pathologically characterized by accumulations of alpha-amylaseresistant glycogen [1] . One recently identified form of polyglucosan body myopathy (glycogen storage disease type XV) is caused by deficiency of glycogenin-1, encoded by GYG1. Glycogenin-1 is a glycosyltransferase forming the priming oligosaccharide chain and constituting a protein core of normal glycogen. The spectrum of diseases caused by glycogenin-1 deficiency ranges from the originally described severe cardiomyopathy without polyglucosan bodies in skeletal muscle [2] , to isolated myopathy with juvenile or adult-onset [3] [4] [5] [6] [7] . Our patient, an 84-year-old male, had progressive pain and weakness in the upper left arm since age 82. Later, the weakness had spread to proximal lower limbs, right upper arm and distal lower limbs. Physical examination showed waddling and stepping gait. He could raise his right arm 30°and left arm 60°. Hypotrophy of the right biceps brachii, forearm, first dorsal interosseous, and right thigh muscles was noticed. Weakness was present in the hand finger extensor (Medical Research Council, MRC 3), tibialis anterior (MRC 3 on the right and 4 on the left), extensor hallucis longus (MRC 2), hip flexor (MRC 3 and 4) and hip extensor (MRC 2) muscles.
Family and previous medical histories were unremarkable, except for a neurosensorial hearing loss that required prosthesis at age 70. A pedigree is shown in Supplemental Figure 1 . Creatine kinase level was normal. Electromyography showed myopathic recruitment together with some large amplitude motor unit potentials and spontaneous activity. No signs of cardiomyopathy were found, and a first-degree atrioventricular block was the only abnormality on electrocardiogram.
Biopsy of the left biceps brachii showed fibers depleted of glycogen and fibers with vacuoles filled with material, which stained intensely positive with periodic acid-Schiff (PAS) and was partly resistant to alpha-amylase treatment. 38 % of the fibers also contained collections of nemaline rods. Electron microscopy confirmed the presence of nemaline rods and areas of myofibrillar disruption often adjacent to the PAS-positive regions, which displayed normal glycogen as well as accumulation of material compatible with polyglucosan ( Fig. 1a-f) . Polyglucosan bodies were also positively immunostained for desmin and sequestosome-1 (p62) (Supplemental Figure 2) MRI showed asymmetric and patchy changes in several muscles (Fig. 1g) . Clinical and pathology findings prompted the direct analysis of GYG1, and a homozygous c.2T[A change was found by Sanger sequencing. This change is supposed to disrupt the initiation codon of the GYG1 gene. Indeed, molecular analyses revealed absence of glycogenin-1 protein (Fig. 1h-k) . A targeted next-generation sequencing of known and candidate muscle genes [8] excluded concomitant mutations in other disease genes including those associated with nemaline myopathy.
Common features of GYG1-related myopathy present in our patient are the asymmetric, proximal and distal muscle weakness and atrophy. On muscle imaging, glutei consistently appear as the most affected muscles in this disease, together with adductor magnus, infraspinatus and deltoid [4] [5] [6] . Our patient also showed neurosensorial hearing loss that has been reported in another GYG1-mutated patient in her 40s [4] .
The presence of nemaline rods is a novel finding. Rods were particularly present close to the polyglucosan accumulations. Z-disk disruption and rod formation are possibly consequences of a perturbed protein turnover, but a definite link is yet to be found. A role of the ubiquitin-proteasome system in handling polyglucosan bodies is suggested by the immunoreactivity with p62 and ubiquitin [3] and by the existence of polyglucosan storage disorders caused by mutations in the ubiquitin ligases RBCK1 and malin [1] . Advanced age at biopsy might also have a role in the development of these abnormalities in our patient. Sporadic late-onset nemaline myopathy (SLONM) can also cause nemaline rod pathology [9] . However, no monoclonal peak was detected in our patient and one infusion of intravenous immunoglobulins (2 g/kg) was performed without clear benefit. During follow-up, the disease had only a slow progression over a 3-year timeframe, without significant bulbar and respiratory impairment, which is another reason that makes SLONM unlikely, as well as a possible concomitant motor neuron disorder.
In conclusion, our case broadens the spectrum of glycogen storage disease XV. The late-onset phenotype and presence of apparently normal glycogen in muscle despite complete loss of glycogenin-1 indicates alternative priming of glycogen synthesis that needs to be further investigated.
b Fig. 1 Muscle pathology, MRI and molecular studies. 
